734 related articles for article (PubMed ID: 30027778)
21. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
[TBL] [Abstract][Full Text] [Related]
22. Nano-sized crystalline drug production by milling technology.
Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
[TBL] [Abstract][Full Text] [Related]
23. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
24. Rutin nanosuspension for potential management of osteoporosis: effect of particle size reduction on oral bioavailability,
Gera S; Pooladanda V; Godugu C; Swamy Challa V; Wankar J; Dodoala S; Sampathi S
Pharm Dev Technol; 2020 Oct; 25(8):971-988. PubMed ID: 32403972
[TBL] [Abstract][Full Text] [Related]
25. Investigating a Novel Hot Melt Extrusion-Based Drying Technique to Solidify an Amorphous Nanosuspension Using Design of Experiment Methodology.
Gajera BY; Shah DA; Dave RH
AAPS PharmSciTech; 2018 Nov; 19(8):3778-3790. PubMed ID: 30280356
[TBL] [Abstract][Full Text] [Related]
26. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
Kassem MAA; ElMeshad AN; Fares AR
AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
[TBL] [Abstract][Full Text] [Related]
27. Formulation and drying of miconazole and itraconazole nanosuspensions.
Cerdeira AM; Mazzotti M; Gander B
Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
[TBL] [Abstract][Full Text] [Related]
28. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
[TBL] [Abstract][Full Text] [Related]
29. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
Marzan AL; Tabassum R; Jahan B; Asif MH; Reza HM; Kazi M; Alshehri SM; de Matas M; Shariare MH
Curr Drug Deliv; 2018; 15(5):672-685. PubMed ID: 29359667
[TBL] [Abstract][Full Text] [Related]
30. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
Karakucuk A; Celebi N; Teksin ZS
Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
[TBL] [Abstract][Full Text] [Related]
31. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
32. Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds.
Komasaka T; Fujimura H; Tagawa T; Sugiyama A; Kitano Y
Chem Pharm Bull (Tokyo); 2014; 62(11):1073-82. PubMed ID: 25366311
[TBL] [Abstract][Full Text] [Related]
33. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
Ghosh I; Schenck D; Bose S; Ruegger C
Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
[TBL] [Abstract][Full Text] [Related]
34. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
Yang H; Teng F; Wang P; Tian B; Lin X; Hu X; Zhang L; Zhang K; Zhang Y; Tang X
Int J Pharm; 2014 Dec; 477(1-2):88-95. PubMed ID: 25455766
[TBL] [Abstract][Full Text] [Related]
35. Investigation into physical-chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticles.
Shahbazi Niaz M; Traini D; Young PM; Ghadiri M; Rohanizadeh R
Pharm Dev Technol; 2014 Dec; 19(8):911-21. PubMed ID: 24093825
[TBL] [Abstract][Full Text] [Related]
36. Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.
Niwa T; Miura S; Danjo K
Pharm Res; 2011 Sep; 28(9):2339-49. PubMed ID: 21626059
[TBL] [Abstract][Full Text] [Related]
37. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study.
Gora S; Mustafa G; Sahni JK; Ali J; Baboota S
Drug Deliv; 2016; 23(3):940-50. PubMed ID: 24937379
[TBL] [Abstract][Full Text] [Related]
38. Optimization of Performance Variables of Exemestane Nanosuspension Using Box-Behnken Design to Improve Dissolution and Oral Bioavailability.
Parmar K; Shah J
Curr Drug Deliv; 2021; 18(8):1148-1161. PubMed ID: 33438540
[TBL] [Abstract][Full Text] [Related]
39. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
40. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
Friedrich H; Nada A; Bodmeier R
Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
